Company · founded 2007
DiscoveryBioMed (United States)
Birmingham, United States · discoverybiomed.com
- Citations, last 5 years
- 21
- Works, last 5 years
- 2
- h-index
- 19
- Scientists listed
- 0
- Grants since 2016
- 12
Grants received
2019 · research · R41
Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery
Nancy Ellen Rawson · DiscoveryBioMed (United States) · funded by National Institutes of Health
2019–2022 · research · R42
Broad Spectrum Bitter Taste Antagonists Discovery
Nancy Ellen Rawson · DiscoveryBioMed (United States) · funded by National Institutes of Health
2019–2020 · research · R43
STING Inhibitor Discovery for Rare and Common Autoimmune Diseases
Shanta Bantia · DiscoveryBioMed (United States) · funded by National Institutes of Health
2019–2023 · research · R42
Broad Spectrum Bitter Taste Antagonists Discovery
Nancy Ellen Rawson · DiscoveryBioMed (United States) · funded by National Institutes of Health
2019–2023 · research · R42
Broad Spectrum Bitter Taste Antagonists Discovery
Nancy Ellen Rawson · DiscoveryBioMed (United States) · funded by National Institutes of Health
2018–2019 · research · R41
Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery
Nancy Ellen Rawson · DiscoveryBioMed (United States) · funded by National Institutes of Health
2018–2020 · research · R44
Humanized Kidney Cellular Toxicity Platforms
Erik Mills Schwiebert · DiscoveryBioMed (United States) · funded by National Institutes of Health
2018–2020 · research · R44
Humanized Kidney Cellular Toxicity Platforms
Erik Mills Schwiebert · DiscoveryBioMed (United States) · funded by National Institutes of Health
2017–2018 · research · R44
Humanized Kidney Cellular Toxicity Platforms
Erik Mills Schwiebert · DiscoveryBioMed (United States) · funded by National Institutes of Health
2016–2019 · research · R44
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
Erik Mills Schwiebert · DiscoveryBioMed (United States) · funded by National Institutes of Health
2016–2017 · research · R44
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
Erik Mills Schwiebert · DiscoveryBioMed (United States) · funded by National Institutes of Health
2016–2019 · research · R44
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
Erik Mills Schwiebert · DiscoveryBioMed (United States) · funded by National Institutes of Health
